InvestorsHub Logo
Followers 215
Posts 22621
Boards Moderated 0
Alias Born 10/22/2006

Re: umiak post# 275033

Wednesday, 06/06/2018 11:40:40 AM

Wednesday, June 06, 2018 11:40:40 AM

Post# of 275594

We look forward to continuing to present new data from our active lysin research programs as we await top-line results from the ongoing Phase 2 trial of CF-301 later this year,” continued Dr. Cassino.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.